Bright Minds Biosciences Inc. (DRUG) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -9.5M | -5.82M | -1.27M | -3.5M | -2.43M | -1.49M | -463.17K | 240.16K | -805.09K | -822.09K | -1.2M | -1.65M | -1.51M | -2.66M | -2.13M | -2.86M | -3.65M | -4.95M | -2.39M | -2.97M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -291.55% | -289.18% | -173.77% | -1559% | -201.24% | -81.78% | 61.32% | 114.55% | 46.77% | 69.14% | 43.74% | 42.33% | 58.51% | 46.2% | 10.92% | 3.72% | -159.01% | -800.97% | -1034.48% | - |
| Net Income | -10.63M | -7.57M | -4.09M | -5.24M | -2.95M | 49.61K | -773.44K | 229.9K | -574.14K | -1.68M | -1.53M | -1.46M | -2.05M | -2.34M | -2.96M | -2.66M | -4.49M | -4.86M | -2.87M | -3.53M |
| Depreciation & Amortization | 20.13K | 19.79K | 17.01K | 15.85K | 22.48K | 21.53K | 19.02K | -29.89K | 18.11K | 18.11K | 18.11K | 18.11K | 18.11K | 18.11K | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 1.29M | 1.07M | 1.32M | 615.91K | 176.39K | 210.24K | 183.94K | 226.64K | 218.95K | 400.5K | 237.53K | 29.96K | 484.14K | 29.91K | 293.38K | 290.83K | 260.93K | 376.56K | 260.8K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -267.5K | 1.44M | 539.89K | 781.3K | 25.34K | -1.62M | -12.37K | 9.64K | 4.29K | 45.27K | 167.22K | -125.89K | 10.66K | 13.1K | -41.25K | 4.28K | 6.99K | -191.38K | -152.29K | 293.25K |
| Working Capital Changes | 1.39M | -996.37K | 1.19M | -379.48K | -138.63K | -118.56K | 93.39K | -153.43K | -479.99K | 579.85K | -255.36K | -322K | 479.25K | -843.6K | 843.75K | -501.36K | 544.2K | -162.47K | 253.12K | 6.67K |
| Change in Receivables | -679.9K | -30.56K | -140.44K | -39.06K | -166.55K | -16.8K | -32.99K | 536.01K | -508.21K | -8.06K | 66.69K | -70.31K | 25.91K | 96.5K | -91.34K | 111.97K | -26.71K | -39.54K | -32.16K | -41.24K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 232.5M | 13.39M | 33.32M | -16.87K | 225.38K | 52.04M | -23.56K | -21.96K | -21.96K | 878.04K | -21.64K | -21.49K | -21.49K | 2.25M | 5.06M | 12K | 1.68K | 118.25K | -9.7K | -545.55K |
| Debt Issued (Net) | 0 | -26.02K | -26.11K | -25.62K | -24.63K | -23.79K | -23.86K | -21.96K | -21.96K | -21.96K | -21.64K | -21.49K | -21.49K | -21.49K | 24.84K | 0 | -32K | 0 | 0 | 0 |
| Equity Issued (Net) | 232.52M | 13.95M | 33.62M | 8.75K | 250.01K | 52.15M | 302 | 0 | 0 | 900K | 0 | 0 | 0 | 1.22M | 4.03M | 0 | 0 | 0 | 0 | -39.25K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -27.14K | -536.12K | -276.42K | 0 | 0 | -83.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.06M | 1M | 12K | 33.68K | 118.25K | -9.7K | -506.3K |
| Net Change in Cash | 218.88M | 6.14M | 31.52M | -4.29M | -2.22M | 52.18M | -470.15K | 257.81K | -829.21K | 13.66K | -1.38M | -1.54M | -1.54M | -416.41K | 2.99M | -2.83M | -3.65M | -4.64M | -2.25M | -3.44M |
| Free Cash Flow | -9.5M | -5.82M | -1.27M | -3.5M | -2.43M | -1.49M | -463.17K | 240.16K | -805.09K | -822.09K | -1.2M | -1.65M | -1.51M | -2.66M | -2.13M | -2.86M | -3.65M | -4.95M | -2.39M | -2.97M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -291.55% | -289.18% | -173.77% | -1559% | -201.24% | -81.78% | 61.32% | 114.55% | 46.77% | 69.14% | 43.74% | 42.33% | 58.51% | 46.2% | 10.92% | 3.72% | -159.01% | -800.97% | -1034.48% | - |
| FCF per Share | -0.99 | -0.75 | -0.18 | -0.49 | -0.52 | -0.32 | -0.10 | 0.05 | -0.18 | -0.21 | -0.32 | -0.44 | -0.40 | -0.74 | -0.71 | -1.21 | -1.54 | -2.09 | -1.01 | -1.31 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.77x | 0.31x | 0.67x | 0.82x | -30.12x | 0.60x | 1.04x | 1.40x | 0.49x | 0.78x | 1.13x | 0.74x | 1.14x | 0.72x | 1.08x | 0.81x | 1.02x | 0.83x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |